Palantir Technologies Inc (NYSE: PLTR) is trading higher Tuesday morning after the company renewed its contract with the UCenters for Disease Control and Prevention.  What Happened: Palantir announced it was awarded a one-year, $7.4-million contract renewal with the CDC to continue to provide an outbreak response and disease surveillance solution for the Data Collation and Integration for Public Health Event Response program.
What's Up With Palantir Today?